Screening for lung cancer

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 6, 2013, Pages

  Manser, Renée ^a,b   Lethaby, Anne ^c   Irving, Louis B ^b   Stone, Christine ^d   Byrnes, Graham ^e   Abramson, Michael J ^f   Campbell, Don ^g  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d Victoria Clinic Prahran   (Australia)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f MONASH UNIVERSITY   (Australia)

^g MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALL CAUSE MORTALITY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CLINICAL OUTCOME; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; LUNG CANCER; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SMOKING; SPUTUM CYTODIAGNOSIS; SPUTUM EXAMINATION; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; ADULT; CONTROLLED CLINICAL TRIAL (TOPIC); CYTOLOGY; FEMALE; LUNG TUMOR; MALE; META ANALYSIS; MORTALITY; PATHOLOGY; RADIOGRAPHY; SPUTUM;

ADULT; CONTROLLED CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; RADIOGRAPHY, THORACIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING; SPUTUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84887373726     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD001991.pub3     Document Type: Review

References (132)

1. Kubik A. Risk groups and effective frequency of X-ray miniature screening of bronchial carcinoma [Risikogruppen und effektive schirmbildscreeningfrequenz des bronchialkrebses]. Zeitchrift fu Erankungen de Atmungsovgane 1983;160(1):18-25.
2. Kubik A, Haerting J. Survival and mortality in a randomised study of lung cancer detection. Neoplasma 1990;37(4):467-75.
3. Kubik A, Parkin DM, Khlat M, Erban J, Polak J. Adamec M. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomised controlled trial on a population of high-risk males in Czechoslavakia. International Journal of Cancer 1990;45(1):26-33.
4. Kubik A, Polak J. Lung cancer detection. Results of a randomized prospective study in Czechoslovakia. Cancer 1986;57:2427-37.
5. Kubik, AK, Parkin DM, Zatioukal P. Czech study on lung cancer screening: Post-trial follow up of lung cancer deaths up to year 15 since enrolment. Cancer 2000;89(Suppl):2363-8.
6. Walter SD, Kubik A, Parkin DM, Reissigova J, Adamec M, Khlat M. The natural history of lung cancer estimated from the results of a randomised trial of screening. Cancer Causes and Control 1992;3(2):115-23.
7. Wilde J. A 10 year follow-up of semi-annual screening for early detection of lung cancer in the Erfurt County, GDR. European Respiratory Journal 1989;2(7):656-62.
8. Wilde J, Durschmied H, Lorenz H, Niegsch G, Schmidt H, Simer HM. Effectiveness of photography screening studies in the early detection of bronchial carcinoma [Effektivitat der schirmbildreihenuntersuchung zur fuhen erfassung des brondhialkarzinoms]. Zeitschrift fur Erkrankigender Atmungsorgane 1983;160:128-41.
9. Baker R, Tockman MS, Marsh BR, Stitik FP, Ball WC, Eggleston JC, et al.Screening for bronchogenic carcinoma: the surgical experience. Journal of Thoracic Cardiovascular Surgery 1979;78:876-82.
10. Frost NK, Ball WC, Levin ML, Tockman MS, Baker RR, Carter D, et al.Early lung cancer detection: results in the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins Study. American Review of Respiratory Disease 1984;130:549-54.
11. Levin ML, Tockman MS, Frost JK, Ball WC. Lung cancer mortality in males screened by chest x-ray and cytologic sputum examination: a preliminary report. Recent Results in Cancer Research 1982;82:138-46.
12. Stitik FP, Tockman MS. Radiographic screening in the early detection of lung cancer. Radiologic Clinics of North America. 1978;16(3):347-66.
13. Tockman MS. Survival and mortality from lung cancer in a screened population. Chest 1986;89(Suppl):324-5.
14. Tockman MS, Frost JK, Stitik FP, Levin ML, Ball WC, Marsh BR. Screening and detection of lung cancer. In: Joseph Aisner editor(s). Lung Cancer. New York: Churchill Livingstone, 1985:25-36.
15. Dales L, Friedman GD, Collen MF. Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases 1979;32:385-404.
16. Friedman G, Collen MF, Fireman BH. Multiphasic health checkup evaluation: a 16 year follow up. Journal of Chronic Diseases 1986;39:453-63.
17. Flehinger BJ, Kimmel M, Polyak T, Melamed MR. Screening for lung cancer. The Mayo Lung Project revisited. Cancer 1993;72(5):1573-80.
18. Fontana RS, Sanderson DR, Taylor WF, Woolner LB, Miller WE, Muhm JR, et al.Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo clinic study. American Review of Respiratory Diseases 1984;130:561-5.
19. Fontana RS, Sanderson DR, Woolner LB, Miller WE, Bernatz PE, Payne WS, et al.The Mayo Lung Project for early detection and localization of bronchogenic carcinoma: a status report. Chest 1975;67(5):511-22.
20. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR. Lung cancer screening: the Mayo program. Journal of Occupational Medicine 1986;28(8):746-50.
21. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR, et al.Screening for lung cancer: a critique of the Mayo Lung Project. Cancer 1991;67(4 Suppl):1155-64.
22. Marcus PM, Bergstrahl EJ, Fagerstrom RM, Williams DE, Fontana RS, Taylor WF, et al.Lung cancer mortality in the Mayo Lung Project: impact of extended follow up. Journal of the National Cancer Institute 2000;92(16):1308-16.
23. Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. Journal of the National Cancer Institute 2006;98(11):748-56.
24. Marcus PM, Prorok PC. Reanalysis of the Mayo Lung Project data: the impact of confounding and effect modification. Journal of Medical Screening 1999;6(1):47-9.
25. Muhm JR, Miller WE, Fontana RS, Sanderson DR, Uhlenhopp MA. Lung cancer detected during a screening program using four month chest radiographs. Radiology 1983;148(3):609-15.
26. Sanderson D, Fontana R. Results of the Mayo Lung Project: an interim report. Recent Results in Cancer Research 1982;82:179-86.
27. Sanderson DR. Lung cancer screening. The Mayo study. Chest 1986;89(4 Suppl):324.
28. Taylor WF, Fontana RS. Biometric design of the Mayo Lung project for early detection and localization of bronchogenic carcinoma. Cancer 1972;30(5):1344-7.
29. Taylor WF, Fontana RS, Uhlenhopp MA, Davis CS. Some results of screening for early lung cancer. Cancer 1981;47:1114-20.
30. Woolner L, Fontana RS, Cortese DA, Sanderson DR, Bernatz PE, Payne WS, et al.Roentgenographically occult lung cancer: pathologic findings and frequency of multicentricity during a 10 year period. Mayo Clinic Proceedings 1984;59:453-66.
31. Woolner LB, Fontana RS, Sanderson DR, Miller WE, Muhm JR, Taylor WF, et al.Mayo Lung Project. Evaluation of lung cancer screening through December 1979. Mayo Clinic Proceedings 1981;56(9):544-55.
32. Flehinger BJ, Kimmel M. The natural history of lung cancer in a periodically screened population. Biometrics 1987;43:127-44.
33. Flehinger BJ, Melamed MR. Current status of screening for lung cancer. Chest Surgery Clinics of North America 1994;4(1):1-15.
34. Flehinger BJ, Melamed MR, Zaman MB, Heelan RT, Perchick WB, Martini N. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. American Review of Respiratory Diseases 1984;130(4):555-60.
35. Heelan RT, Flehinger BJ, Melamed MR, Zaman MB, Perchick WB, Caravelli JF, et al.Non-small-cell lung cancer: results of the New York screening program. Radiology 1984;151:289-93.
36. Martini N. Results of the Memorial Sloan-Kettering study in screening for early lung cancer. Chest 1986;89(4 Suppl):325.
37. Melamed M, Flehinger BJ, Miller D, Osborne R, Zaman M, McGinnis C, et al.Preliminary report of the Lung Cancer Detection Program in New York. Cancer 1977;39:369-82.
38. Melamed MR, Flehinger BJ, Zaman MB. Impact of early detection on the clinical course of lung cancer. Surgical Clinics of North America 1987;67(5):909-24.
39. Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 1984;86(1):44-53.
40. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. New England Journal of Medicine 2011;365(5):395-409.
41. National Lung Screening Trial Research Team. The National Lung Screening Trial: overview and study design. Radiology 2011;258(1):243-53.
42. Anon. Lung cancer detection by chest x-rays at 6 monthly intervals. Nova Scotia Medical Bulletin 1970;49(1):14-5.
43. Brett G. The presymptomatic diagnosis of lung cancer. Proceedings of the Royal Society of Medicine 1966;59:1208.
44. Brett G. The value of lung cancer detection by 6 monthly chest radiographs. Thorax 1968;23:414-20.
45. Brett GZ. Earlier diagnosis and survival in lung cancer. British Medical Journal 1969;4(678):260-2.
46. Hocking WG, Hu P, Oken MM, Winslow SD, Kvale PA, Prorok PC, et al.Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Journal of the National Cancer Institute 2010;102(10):722-31.
47. Kramer BS, Gohagan J, Prorok PC. A randomised study of chest x-ray screening for lung cancer as part of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Trial. Lung Cancer 1994;11(Suppl 2):82-3.
48. Oken MM, Marcus PM, Hu P, Beck TM, Hocking Wm Kvale PA, et al.Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Journal of the National Cancer Institute 2005;97(24):1832-9.
49. Oken, MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, et al.Screening by chest radiograph and lung cancer mortality. The Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011;306(17):1865-73.
50. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, et al.Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Controlled Clinical Trials 2000;21:273S-309S.
51. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA 2007; Vol. 297, issue 9:953-61.
52. Blanchon T, Bréchot J-M, Grenier PA, Ferretti GR, Lemarié E, Milleron B, et al.Baseline results of the Depiscan study: A French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest x-ray (CXR). Lung Cancer 2007;58:50-8.
53. Diederich S, Wormanns D, Lenzen H, Semik M, Thomas M, Peters PE. Screening for asymptomatic early bronchogenic carcinoma with low dose CT of the Chest. Cancer 2000;89(Suppl):2483-4.
54. Diederich S, Wormanns D, Semik M, Thomas M, Lenzen H, Roos N, et al.Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 2002;222(3):773-81.
55. Ebeling K, Nischan P. Screening for lung cancer - results from a case-control study. International Journal of Cancer 1987;40(2):141-4.
56. Garg K, Keith RL, Byers T, Kelly K, Kerzner AL, Lynch DA, et al.Randomized controlled trial with low-dose spiral CT for lung cancer screening: feasibility study and preliminary results. Radiology 2002;225(2):506-10.
57. Gohagan JK, Marcus PM, Fagerstrom RM, Pinsky PF, Kramer BS, Prorok PC, et al.Final results of the Lung Screening Study, a randomised feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 2005;47:9-15.
58. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, et al.Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999;354:99-105.
59. Henschke C, Naidich DP, Yankelevitz DF, McGuinness G, McCauley DI, Smith JP, et al.Early Lung Cancer Action Project: initial findings on repeat screening. Cancer 2001;92:153-9.
60. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage 1 lung cancer detected on CT screening. New England Journal of Medicine 2006;355(17):1763-71.
61. Kakinuma R, Ohmatsu H, Kaneko M, Eguchi K, Naruke T, Nagai K, et al.Detection failures in spiral CT screening for lung cancer: analysis of CT findings. Radiology 1999;212:61-6.
62. Kaneko M, Eguchi K, Ohmatsu H, Kakinuma R, Naruke T, Suemasa K, et al.Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996;201(3):798-802.
63. Matsumoto M, Horikoshi H, Moteki T, Hatori N, Tateno Y, Iinuma T, et al.A pilot study with lung-cancer screening CT (LSCT) at the secondary screening for lung cancer detection. Nippon Igaku Hoshasen Gakkai Zasshi [Nippon Acta Radiologica] 1995;55(3):172-9.
64. Nawa T, Nakagawa T, Kusano S, Kawasaki Y, Sugawara Y, Nakata H. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest 2002;122:15-20.
65. Sobue T, Suzuki T, Naruke T, Japanese lung-cancer-screening research group. A case control study for evaluating lung cancer screening in Japan. International Journal of Cancer 1992;50(2):230-7.
66. Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, et al.Screening for lung cancer with low-dose helical computed tomography: Anti-Lung Cancer Association project. Journal of Clinical Oncology 2002;20(4):911-20.
67. Sone S, Takashima S, Li F, Yang Z, Honda T, Maruyama Y, et al.Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998;351(9111):1242-5.
68. Sone S, Li F, Yang Z-G, Honda T, Maruyama Y, Takashima S, et al.Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. British Journal of Cancer 2001;84(1):25-32.
69. Swensen SJ, Jett JR, Sloan JA, Midthun DE, Hartman TE, Sykes AM, et al.Screening for lung cancer with low-dose spiral computed tomography. American Journal of Respiratory and Critical Care Medicine 2002;165:508-13.
70. Tiitola M, Kivisaari L, Huuskonen MS, Mattson K, Koskinen H, Lehtola H, et al.Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer 2002;35:17-22.
71. Yang M, Wang J, Meng L-J, Wang Y, Xu L, Liu F-Y, et al.Analysis of feasibility of lung cancer screening with low-radiation-dose spiral CT scan plus detection of p16 gene methylation in serum. Chinese Journal of Cancer Prevention and Treatment 2008;15(1):8-10.
72. Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G Ceresoli G, et al.A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. American Journal of Respiratory and Critical Care Medicine 2009;180:445-53.
73. Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clemensten PF, et al.CT screening for lung cancer brings forward early disease. The Randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 2012;67:296-301.
74. Pegna AL, Picozzi G, Mascalchi M, Carrozzi FM, Carozzi L, Comin C, et al.Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009;64:34-40.
75. Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, et al.Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. Journal of Cancer Research and Clinical Oncology 2012;138(9):1475-86.
76. Pastorino U, Rossi M, Rosato V, Marchianò A, Sverzellati N, Morosi C, et al.Annual or biennial CT screening versus observation in heavy smokers: 5 year results of the MILD trial. European Journal of Cancer Prevention 2012;21:308-15.
77. Van Lersel CA, De Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K, et al.Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian Randomised Lung Cancer Multi-slice CT Screening Trial (NELSON). International Journal of Cancer 2006;120:868-74.
78. Zhao, YR, Xie X, De Koning HJ, Mali WP, Vliegenthart R, Oudkerk M. NELSON lung cancer screening study. Cancer Imaging 2011;11:S79-S84.
79. American Cancer Society. Report on the cancer related health checkup: cancer of the lung. CA: A Cancer Journal for Clinicians 1980;30:199-207.
80. Bach PB, Silvestri GA, Hauger M, Jett JR. Screening for lung cancer. ACCP evidence-based clinical practice guidelines. Chest 2007;132(2 Suppl):69S-77S.
81. Bailar JC. Screening for lung cancer - where are we now?. Am Rev Respir Dis 1984;130(4):541-2.
82. Bailar J, Gornick HL. Cancer undefeated. New England Journal of Medicine 1997;336:1569-74.
83. Berlin I, Buncher CR, Fontana RS, Frost JK, Melamed MR. The National Cancer Institute cooperative early lung cancer detection program. Results of the initial screen (prevalence). Early lung cancer detection: introduction. American Review of Respiratory Disease 1984;130(4):545-9.
84. Black WC. Overdiagnosis: an under recognised cause of confusion and harm in cancer screening. Journal of the National Cancer Institute 2000;92(16):1280-2.
85. Bland J, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995;310:170.
86. Boshuizen R, Kuhn P, Van den Heuvel M. Circulating tumor cells in non-small cell lung carcinoma. Journal of Thoracic Disease 2012;4(5):456-8.
87. Brenner DJ. Radiation risks potentially associated with low-dose CT screening in adult smokers for lung cancer. Radiology 2004;231:440-5.
88. Carpagnano GE, Foschino-Barbaro MP, Spanevello A, Resta O, Carpagnano F, Mulé G, et al.3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer. American Journal of Respiratory Critical Care Medicine 2005;172:738-44.
89. Chalmers TC, Celano P, Sacks HS, Smith H Jr. Bias in treatment assignment in controlled clinical trials. New England Journal of Medicine 1983;309:1358-61.
90. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
91. Diederich S, Lenzen H. Radiation exposure associated with imaging of the chest. Cancer 2000;89(Supplement):2457-60.
92. Dominion L, Poli A, Montovani W, Rotolol N, Imperatori A. Volunteer effect and compromised randomisation in the Mayo Project of screening for lung cancer. European Journal of Epidemiology 2011;26:79-80.
93. Doria-Rose VP, Marcus PM, Szabo E, Tockman MS, Melamed MR, Prorok PC. Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer 2009;115:5007-17.
94. Eddy DM. Screening for lung cancer. Annals of Internal Medicine 1989;111(3):232-7.
95. Fontana RS, Sanderson DR, Taylor WF, Woolner LB, Miller WE, Muhm JR, et al.Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo clinic study. American Review of Respiratory Disease 1984;130(4):561-5.
96. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr (accessed 29th December 2012).
97. Godoy MC, Sabloff B, Naidich DP. Subsolid pulmonary nodules: imaging evaluation and strategic management. Current Opinion in Pulmonary Medicine 2012;18(4):304-12.
98. Halpern M, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. Journal of the National Cancer Institute 1993;85:457-63.
99. Higgins JPT, Thompson SJ, Deeks JJ, Altman DJ. Measuring inconsistencies in meta-analyses. BMJ 2003;327:557-560.
100. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics 2009. CA: A Cancer Journal for Clinicians 2009;59:225-49.
101. Kernan WN, Viscoli CM, Makuch RW, Brass LM, Horwitz RI. Stratified randomisation for clinical trials. Journal of Clinical Epidemiology 1999;52:19-26.
102. Kerry SM, Bland JM. Analysis of a trial randomised in clusters. BMJ 1998;316:54.
103. Kubik AP, Polak J. Lung cancer detection. Results of a randomised prospective study in Czechoslovakia. Cancer 1986;57:2427-37.
104. Lopez A. The lung cancer epidemic in developed countries. Adult mortality in developed countries: from description to explanation. Oxford: Clarendon Press, 1995:111-34.
105. Ma J, Ward EM, Smith R, Jemal A. Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer 2013;119:1381-5.
106. Machado RF, Laskowski D, Deffenderfer O, Burch T, Zheng S, Mazzone PJ, et al.Detection of lung cancer by sensor array analyses of exhaled breath. American Journal of Respiratory Critical Care Medicine 2005;171:1286-91.
107. Mahadevia PJ, Fleisher LA, Frick KD, Eng J, Goodman SN, Powe NR. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. JAMA 2003;289(3):313-22.
108. Mong C, Garon EB, Fuller C, Mahtabifard A, Mirocha J, Mosenifar Z, et al.High prevalence of lung cancer in a surgical cohort of lung cancer patients a decade after smoking cessation. Journal of Cardiothoracic Surgery 2011;6:19.
109. Patz E, Goodman PC, Bepler G. Screening for lung cancer. New England Journal of Medicine 2000;343:1627-33.
110. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al.Design and analysis of randomised clinical trials requiring prolonged observation of each patient. British Journal of Cancer 1976;34:585.
111. Phillips M, Gleeson K, Hughes JM, Greenberg J, Cataneo RN, Baker L, et al.Volatile organic compounds in breath as markers for lung cancer: a cross sectional study. Lancet 1999;353:1930-3.
112. Phillips M, Cataneo RN, Cummin AR, Gagliardi AJ, Gleeson K, Greenberg J, et al.Detection of lung cancer with volatile markers in the breath. Chest 2003;123:2115-23.
113. Rahman SM, Shyr Y, Yildiz PB, Gonzalez AL, Li H, Zhang X, et al.Proteomic patterns of preinvasive bronchial lesions. American Journal of Respiratory Critical Care Medicine 2005;172(12):1556-62.
114. Raji OY, Duffy SW, Agbaje OF, Baker SG, Christiani DC, Cassidy A, et al.Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study. Annals of Internal Medicine 2012;157(4):242-50.
115. The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2008.
116. Ries LA. Influence of extent of disease, histology and demographic factors on lung cancer survival in the seer population-based data. Seminars in Surgical Oncology 1994;10(1):21-30.
117. Schoenborn CA, Adams PF, Peregoy JA. Health behaviors of adults: United States, 2008-2010. National Center for Health Statistics. Vital Health Statistics 2013;10(257):21-4.
118. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
119. Tockman MS. Survival and mortality from lung cancer in a screened population. Chest 1986;89:S324-S325.
120. Tockman M, Anthonisen NR, Wright EC, Donithan MG. Airways obstruction and the risk for lung cancer. Annals of Internal Medicine 1987;106:512-8.
121. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al.International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. Journal of Thoracic Oncology 2011;6(2):244-85.
122. Welch HG, Woloshin S, Schwartz LM, Gordis L, Gotzsche PC, Harris R, et al.Overstating the evidence for lung cancer screening. Archives of Internal Medicine 2007;167(21):2289-95.
123. Welch HG, Black WC. Overdiagnosis in cancer. Journal of the National Cancer Institute 2010;102:605-13.
124. World Health Organization. The top 10 causes of death. World Health Organization, Media Centre, Fact Sheet 310 (updated June 2011). Available at www.who.int/mediacentre/factsheets/fs310/en/index.html (accessed 26th January 2013).
125. Wilde J. A 10 year follow-up of semi annual screening for for early detection of lung cancer in the Efurt County, GDR. European Respiratory Journal 1989;2(7):656-62.
126. Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, Fisher SN, et al.Association of radiographic emphysema and airflow obstruction with lung cancer. American Journal of Respiratory and Critical Care Medicine 2008;178(7):738-44.
127. Woo B, Woo B, Cook EF, Weisberg M, Goldman L. Screening procedures in the asymptomatic adult: comparison of physicians' recommendations, patients' desires, published guidelines and actual practice. JAMA 1985;254:1480-4.
128. Young RP, Hopkins RJ. Diagnosing COPD and targeted lung cancer screening (correspondence). European Respiratory Journal 2012;40(4):1063-4.
129. Zhong L, Hidalgo GE, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Using protein microarray as a diagnostic assay for non-small cell lung cancer. American Journal of Respiratory Critical Care Medicine 2005;172:1308-14.
130. Manser RL, Irving LB, Stone C, Byrnes G, Abramson M, Campbell D. Screening for lung cancer. Cochrane Database of Systematic Reviews 1999, Issue 3. [DOI: 10.1002/14651858.CD001991]
131. Manser R, Irving LB, Stone C, Byrnes G, Abramson MJ, Campbell D. Screening for lung cancer. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD001991.pub2]
132. Manser R, Irving LB, Stone C, Byrnes G, Abramson MJ, Campbell D. Screening for lung cancer. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD001991.pub2]